Carlson, A. M., Maurer, M. J., Goergen, K. M., Kalli, K. R., Erskine, C. L., Behrens, M. D., . . . Block, M. S. (2013). Utility of progranulin and serum leukocyte protease inhibitor as diagnostic and prognostic biomarkers in ovarian cancer.
Citação norma ChicagoCarlson, Aaron M., Matthew J. Maurer, Krista M. Goergen, Kimberly R. Kalli, Courtney L. Erskine, Marshall D. Behrens, Keith L. Knutson, and Matthew S. Block. Utility of Progranulin and Serum Leukocyte Protease Inhibitor As Diagnostic and Prognostic Biomarkers in Ovarian Cancer. 2013.
MLA citiranjeCarlson, Aaron M., et al. Utility of Progranulin and Serum Leukocyte Protease Inhibitor As Diagnostic and Prognostic Biomarkers in Ovarian Cancer. 2013.
Opozorilo: Ti citati niso vedno 100% točni.